Abstract 1755: IKS03, a CD19-targeted Antibody Drug Conjugate with Enhanced Efficacy and Tolerability for Treatment of B-cell Lymphomas
Cancer research（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined